JACQUELINE FLAHERTY: Open Payments
NPI 1316622640 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 65 payments from 9 companies in 2025. Trend: 2023 $249 · 2024 $2,314 · 2025 $1,022
Food & beverage: $948Education: $75
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $319 |
| ABBVIE INC. | 30 | $298 |
| E.R. Squibb & Sons, L.L.C. | 7 | $179 |
| Janssen Biotech, Inc. | 4 | $75 |
| Lilly USA, LLC | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| PFIZER INC. | 1 | $22 |
| Organon LLC | 2 | $18 |
| GENZYME CORPORATION | 1 | $17 |
Products named: Bimzelx, SKYRIZI, Sotyktu, RINVOQ, TREMFYA, DUPIXENT, TALTZ, CIBINQO.
Industry payments across MA — which companies pay providers there.
